MetLife director acquires 618 shares via plan

MetLife director Robert Glenn Hubbard added shares via dividend reinvestment under a deferred compensation plan, increasing his directly held common stock to 108,191 shares.

Available on EDGAR 09/10/2026 - 04:03 PM EDT Accepted by SEC EDGAR 09/10/2026 - 04:02 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

METLIFE INC (MET) director Robert Glenn Hubbard reported an acquisition of company common stock on September 8, 2026. He received 618 shares at an imputed price of $95.50 per share through reinvestment of dividends on deferred shares under MetLife’s Deferred Compensation Plan for Non-Management Directors, bringing his directly held stake to 108,191 shares. The transaction was a compensation-related grant/award acquisition, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 618 shares

Grant/Award 1 txn

Insider HUBBARD ROBERT GLENN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	618	$95.50	$59K

Holdings After Transaction: Common Stock — 108,191 shares (Direct)

Holdings Before and After: Common Stock, 107,573 to 108,191 shares (Direct)

Footnotes (1)

1. F1. Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Key Figures

Shares acquired: 618 shares Imputed price per share: $95.50 per share Holdings after transaction: 108,191 shares +1 more

4 metrics

Shares acquired 618 shares Grant/award acquisition of MetLife common stock on September 8, 2026

Imputed price per share $95.50 per share Imputed reinvestment price for the 618 acquired shares

Holdings after transaction 108,191 shares Robert Glenn Hubbard’s directly held MetLife common stock after the acquisition

Transaction date September 8, 2026 Date of the compensation-related share acquisition

Key Terms

MetLife Deferred Compensation Plan for Non-Management Directors, deferred shares, imputed reinvestment of dividends

3 terms

MetLife Deferred Compensation Plan for Non-Management Directors financial

"pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors"

deferred shares financial

"Deferred shares represent shares of MetLife, Inc. common stock"

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

imputed reinvestment of dividends financial

"Imputed reinvestment of dividends on deferred shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MET (MetLife Inc) report for Robert Glenn Hubbard?

MetLife reported that director Robert Glenn Hubbard acquired 618 shares of MetLife common stock on September 8, 2026 through a compensation-related grant/award transaction tied to the company’s deferred compensation plan for non-management directors.

At what price were the newly acquired MET shares attributed in this Form 4?

The 618 MetLife (MET) shares were attributed an imputed price of $95.50 per share, reflecting reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

How many MET shares does Robert Glenn Hubbard hold after this reported transaction?

Following the September 8, 2026 transaction, Robert Glenn Hubbard directly holds 108,191 shares of MetLife Inc common stock, as reported in the Form 4 filing.

What is the nature of the MET shares acquired by Robert Glenn Hubbard in this filing?

The acquired MetLife (MET) shares represent imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares are shares that have become payable but whose receipt the director has chosen to defer.

Was Robert Glenn Hubbard’s MET share acquisition made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not selected, so this 618-share acquisition was reported without being made under an affirmed Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUBBARD ROBERT GLENN

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		A(1)		618	A	$95.5	108,191	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Remarks:

	/s/ Morgan Keehner-Jones Mayes, Attorney-in-fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)